Related Experiment Video
Updated: Apr 17, 2026

Optimizing Isolation and Purification of Murine Glomerular Mesangial Cells
Published on: March 7, 2025
Monoclonal gammopathy associated membranous glomerulonephritis: A rare entity
K K Gowda1, K Joshi1, R Ramachandran2
1Department of Histopathology, PGIMER, Chandigarh, India.
Insights
A rare case of membranous glomerulonephritis (MGN) with monoclonal gammopathy was diagnosed in a 40-year-old male. Treatment with bortezomib, thalidomide, and dexamethasone led to partial remission.
Area of Science:
- Nephrology
- Immunopathology
Background:
- Membranous glomerulonephritis (MGN) is a leading cause of nephrotic syndrome in adults.
- Monoclonal gammopathy, particularly with immunoglobulin G3-kappa, is an uncommon association with MGN.
Observation:
- A 40-year-old male presented with nephrotic syndrome and biopsy findings consistent with MGN.
- Immunofluorescence revealed characteristic IgG3-kappa and C3 deposition along the glomerular basement membrane.
- Electron microscopy confirmed subepithelial electron-dense deposits.
Findings:
- The patient was diagnosed with a rare entity: MGN associated with monoclonal gammopathy.
- Treatment involved a combination regimen of bortezomib, thalidomide, and dexamethasone.
Implications:
- This case highlights the importance of investigating monoclonal gammopathies in patients with MGN.
- The observed partial remission suggests potential efficacy of this treatment regimen in select cases.
- Further research is warranted to understand the pathogenesis and optimal management of this rare condition.
Abstract:
A 40-year-old male presented with nephrotic syndrome. Light microscopic analysis of the renal biopsy showed thickening of the glomerular capillary wall. Immunofluorescence examination revealed granular deposition of monoclonal immunoglobulin (Ig) G3-kappa and complement C3 along the glomerular basement membrane. Electron microscopy showed subepithelial electron dense deposits, thus confirming membranous glomerulonephritis (MGN) with monoclonal gammopathy. MGN with monoclonal gammopathy is an extremely rare but distinctive entity. This patient was treated with a combination of bortezomib, thalidomide and dexamethasone and showed partial remission of his nephrotic state and dysproteinemia.
More Related Videos
09:58Digestion of Whole Mouse Eyes for Multi-Parameter Flow Cytometric Analysis of Mononuclear Phagocytes
Published on: June 17, 2020
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Nephrotic Syndrome I : Introduction
Cytomegalovirus Disease
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Proteoglycans